This startup utilizes a machine-learning algorithm to design customized gene regulatory elements, such as promoters and enhancers, tailored for specific human or mouse cell types within a day. By providing precise regulatory components, the company enhances transgene expression efficiency and reduces off-target effects in gene and cell therapy applications.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for designing gene regulatory elements, such as promoters and enhancers, are time-consuming and often result in off-target effects in gene and cell therapy applications. This inefficiency hinders the development of targeted and effective therapies.
Solution
This startup offers a machine-learning-driven platform that designs customized gene regulatory elements tailored for specific human or mouse cell types. The platform analyzes multiple databases to identify optimal components for constructing regulatory elements, delivering designs within a day. By using these customized elements, researchers can enhance transgene expression efficiency, reduce off-target effects, and control the timing of gene expression in gene and cell therapy products. The technology reduces the time and resources required for designing and testing regulatory elements, providing a faster and more accurate solution.
Target Audience
The primary customers are researchers and companies in the gene and cell therapy fields who need efficient and specific regulatory elements for their products, as well as those transfecting cells with DNA plasmids.
Features
- Machine-learning algorithm that screens multiple databases to identify optimal regulatory components.
- Customized designs for promoters, enhancers, insulators, and silencers.
- Rapid design turnaround, delivering results within a day.
- Capability to target specific human or mouse cell types.
- Designs that reduce the size of DNA plasmids.
- Increased transfection efficiency and reduced toxicity in cells.
- Adjustable criteria for product length and targeting species.